TRCT
ZURA icon

Tower Research Capital (TRC)’s Zura Bio ZURA Stock Holding History

Tower Research Capital (TRC)’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Buy
+3,383
New +$16.1K ﹤0.01% 3561
2026
Q1 		– Sell
-8,280
Closed -$43.4K – 5637
2025
Q4 		$43.4K Buy
8,280
+8,094
+4,352% +$32K ﹤0.01% 2529
2025
Q3 		$805 Sell
186
-21,843
-99% -$39.3K ﹤0.01% 4938
2025
Q2 		$23.1K Buy
22,029
+14,181
+181% +$17K ﹤0.01% 3595
2025
Q1 		$10.1K Buy
7,848
+4,134
+111% +$6.52K ﹤0.01% 3674
2024
Q4 		$9.29K Buy
3,714
+560
+18% +$2K ﹤0.01% 3918
2024
Q3 		$12.8K Sell
3,154
-4,067
-56% -$15.2K ﹤0.01% 3562
2024
Q2 		$25.3K Buy
7,221
+2,914
+68% +$11.9K ﹤0.01% 3612
2024
Q1 		$11.1K Buy
4,307
+1,584
+58% +$5.61K ﹤0.01% 3607
2023
Q4 		$12.7K Buy
2,723
+965
+55% +$4.82K ﹤0.01% 4025
2023
Q3 		$11.6K Buy
1,758
+486
+38% +$3.25K ﹤0.01% 3973
2023
Q2 		$10.4K Buy
1,272
+1,172
+1,172% +$9.41K ﹤0.01% 4122
2023
Q1 		$1K Buy
+100
New +$1.22K ﹤0.01% 5636

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Tower Research Capital (TRC)'s ZURA Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Zura Bio (ZURA) in Q2 2026: 3,383 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #3561 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in ZURA as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in ZURA in Q1 2023 and has held it in 13 quarters since. The position peaked at $43.4K in Q4 2025. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Tower Research Capital (TRC) held 3,383 shares of Zura Bio worth $20K as of Q2 2026.
  • Zura Bio was a new Tower Research Capital (TRC) position in Q2 2026.
  • Zura Bio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3561 holding.
  • Tower Research Capital (TRC) first reported a position in Zura Bio in Q1 2023 and has held it in 13 quarters since.
  • Tower Research Capital (TRC)'s Zura Bio position peaked at $43.4K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.